Cargando…

ELIGANT: a Phase 4, interventional, safety study of leuprorelin acetate (ELIGARD(®)) in Asian men with prostate cancer

BACKGROUND: The incidence and mortality rate of men with prostate cancer have been increasing in Asia. ELIGARD(®) is a formulation of leuprorelin acetate whose safety and efficacy have been well-established in Western regions. However, limited safety data are available for Asian populations. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malek, Rohan, Wu, Sheng-Tang, Serrano, Dennis, Tho, Tran, Umbas, Rainy, Teoh, Jeremy, Lojanapiwat, Bannakji, Ong, Teng Aik, On, Weber Kam, Thai, Sam Minh, Kim, Janet, Pophale, Rupesh, Chiong, Edmund
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899139/ https://www.ncbi.nlm.nih.gov/pubmed/35280654 http://dx.doi.org/10.21037/tau-21-723

Ejemplares similares

Efficacy and tolerability of 1- and 3-month leuprorelin acetate depot formulations (Eligard(®)/Depo-Eligard(®)) for advanced prostate cancer in daily practice: a Belgian prospective non-interventional study
por: Braeckman, Johan, et al.
Publicado: (2014)

Clinical studies investigating the use of leuprorelin for prostate cancer in Asia
por: Chung, Byung Ha, et al.
Publicado: (2020)

Efficacy and safety of therapies for advanced prostate cancer in Asia: Evidence from a systematic literature review
por: Saad, Marniza, et al.
Publicado: (2022)

Foreign Body Granuloma Secondary to Leuprorelin Acetate
por: Lee, Bo In, et al.
Publicado: (2014)

Interstitial pneumonitis secondary to leuprorelin acetate for prostate cancer
por: Tan, Hsern Ern, et al.
Publicado: (2016)

Efficacy of Leuprorelide acetate (Eligard®) in daily practice in Brazil: a retrospective study with depot formulations in patients with prostate cancer
por: de Freitas, Carla S. M., et al.
Publicado: (2020)

Therapeutic Effects of Leuprorelin (Leuprolide Acetate) in Sexual Offenders with Paraphilia
por: Choi, Jong Hyuk, et al.
Publicado: (2018)

Development of Self-Administered Formulation to Improve the Bioavailability of Leuprorelin Acetate
por: Okada, Akie, et al.
Publicado: (2022)

Six-month depot formulation of leuprorelin acetate in the treatment of prostate cancer
por: Sethi, Rajni, et al.
Publicado: (2009)

Six-month leuprorelin acetate depot formulations in advanced prostate cancer: a clinical evaluation
por: Tunn, Ulf W, et al.
Publicado: (2013)

Hepatitis B Virus Reactivation after Receiving Cancer Chemotherapy under Administration of Leuprorelin Acetate
por: Yamauchi, Ryo, et al.
Publicado: (2020)

Successful recovery from multiple organ failure associated with bicalutamide and leuprorelin acetate for prostate cancer
por: Saito, Seiichi
Publicado: (2019)

Foreign Body Granulomas Induced by Intramuscular Leuprorelin Acetate Injection for Prostate Cancer: Clinical Mimics of Soft Tissue Sarcoma
por: Thway, Khin, et al.
Publicado: (2015)

The efficacy and safety of Kuntai capsule combined with leuprorelin acetate in the treatment of endometriosis: A protocol for systematic review and meta-analysis
por: Zhang, Shuzhen, et al.
Publicado: (2021)

The Protective Effect of Lycopene on Prostate Growth Inhibitory Efficacy by Decreasing Insulin Growth Factor-1 in Indonesian Human Prostate Cancer Cells
por: Tjahjodjati,, et al.
Publicado: (2020)

Report of the third Asian Prostate Cancer study meeting
por: Lojanapiwat, Bannakij, et al.
Publicado: (2019)

A Case of Paraphilia with Osteoporosis and Administered with Depot Leuprorelin
por: Kim, Dohee, et al.
Publicado: (2019)

The possible anti-inflammatory role of circulating human leukocyte antigen levels in women with endometriosis after treatment with danazol and leuprorelin acetate depot.
por: Matalliotakis, I M, et al.
Publicado: (2001)

Leuprorelin depot injection: patient considerations in the management of prostatic cancer
por: Abouelfadel, Zinelabidine, et al.
Publicado: (2008)

A Case of Mental Retardation with Paraphilia Treated with Depot Leuprorelin
por: Park, Woo Sung, et al.
Publicado: (2014)

Leuprorelin/tamoxifen: Impairment of ventricular repolarisation reserve: case report
Publicado: (2021)

Leuprorelin Acetate Long-Lasting Effects on GnRH Receptors of Prostate Cancer Cells: An Atomic Force Microscopy Study of Agonist/Receptor Interaction
por: Lama, Gina, et al.
Publicado: (2013)

Is High-Dose Leuprorelin Acetate Effective and Safe in Asian Men with Prostate Cancer? An Open-Label, Non-Comparative, Multi-Center Clinical Trial
por: Lee, Seung-Hwan, et al.
Publicado: (2014)

Growth hormone in combination with leuprorelin in pubertal children with idiopathic short stature
por: Benabbad, Imane, et al.
Publicado: (2018)

Outcomes and predictors of localized or locally-advanced prostate cancer treated by radiotherapy in Indonesia
por: Supit, Wempy, et al.
Publicado: (2013)

Anxiety level of early- and late-stage prostate cancer patients
por: Johanes, Charles, et al.
Publicado: (2013)

Asia prostate cancer study (A-CaP Study) launch symposium
por: Akaza, Hideyuki, et al.
Publicado: (2016)

Report of the Second Asian Prostate Cancer (A-CaP) Study Meeting
por: Kim, Choung-Soo, et al.
Publicado: (2017)

Clinical outcomes of abiraterone acetate and predictors of its treatment duration in metastatic castration‐resistant prostate cancer: Real‐world experience in the Southeast Asian cohort
por: Lim, Jasmine, et al.
Publicado: (2020)

Scoping review: hotspots for COVID-19 urological research: what is being published and from where?
por: Qu, Liang G., et al.
Publicado: (2020)

Anastrozole plus leuprorelin in early maturing girls with compromised growth: the “GAIL” study
por: Papadimitriou, D. T., et al.
Publicado: (2015)

Sex Hormone Dependency of Diethylnitrosamine‐induced Liver Tumors in Mice and Chemoprevention by Leuprorelin
por: Nakatani, Tamaki, et al.
Publicado: (2001)

Long term control of luteinized thecoma with sclerosing peritonitis with leuprorelin and tamoxifen treatment
por: Muratori, L., et al.
Publicado: (2019)

Clinical Studies Investigating the Use of Leuprorelin in Breast Cancer Patients from Asia
por: Han, Wonshik, et al.
Publicado: (2019)

Diffuse Leukoplakia of the Bladder Ostium-Sparing in Patient Treated with Leuprorelin for Breast Cancer
por: Nacchia, Antonio, et al.
Publicado: (2021)

Efficacy and safety of leuprorelin acetate 6-month depot in prostate cancer patients: a Phase III, randomized, open-label, parallel-group, comparative study in Japan
por: Suzuki, Kazuhiro, et al.
Publicado: (2015)

The impact of obesity towards prostate diseases
por: Parikesit, Dyandra, et al.
Publicado: (2016)

Prostate specific antigen (PSA) kinetic as a prognostic factor in metastatic prostate cancer receiving androgen deprivation therapy: systematic review and meta-analysis
por: Afriansyah, Andika, et al.
Publicado: (2018)

A dose-comparative endocrine-clinical study of leuprorelin in premenopausal breast cancer patients.
por: Dowsett, M., et al.
Publicado: (1990)

Degarelix vs. leuprorelin for the treatment of prostate cancer in China: A cost-utility analysis
por: Yan, Jianzhou, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_proq7662l68hg6hg2meca37hvj